Biogen Agrees To One Of Largest FCA Settlements Without DOJ Intervention

Whistleblower
Biogen agrees to settle whistleblower suit alleging it provided kickbacks to get physicians to prescribe its multiple sclerosis drugs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from Compliance